Related by context. All words. (Click for frequent words.) 78 Chronic Myeloid Leukemia 78 Advanced Melanoma 78 Renal Cell Carcinoma 78 Breast Cancer Recurrence 77 Metastatic Colorectal Cancer 77 Gastric Cancer 77 Prolongs Survival 76 Soft Tissue Sarcoma 76 Adjuvant Treatment 76 Hepatocellular Carcinoma 76 Advanced Renal Cell 76 Adjuvant Chemotherapy 75 Chronic Lymphocytic Leukemia 75 Pooled Analysis 75 Stomach Cancer 75 Slow Progression 75 Breast Cancers 75 Leukemias 75 Hormone Refractory Prostate Cancer 75 Cutaneous T 75 Myelodysplastic Syndromes 75 Survival Benefit 75 Adjuvant Therapy 75 Improves Survival 75 Metastatic Prostate Cancer 74 Improves Outcomes 74 Squamous Cell Carcinoma 74 Gene Mutation 74 Glioblastoma Multiforme 74 Endometrial Cancer 74 Improved Survival 74 B Cell Lymphoma 74 Lupus Nephritis 74 Advanced Prostate Cancer 74 Phase 2b Clinical Trial 74 Combination REOLYSIN R 74 Glioma 74 Improve Survival 74 Disease Progression 74 HER2 Positive Breast Cancer 74 Severe Sepsis 74 Carcinoma 74 Mouse Model 74 Metastatic Melanoma 73 Prostate Cancer Patients 73 Autoimmune Disease 73 Invasive Breast Cancer 73 Metastases 73 Chronic Sinusitis 73 Genes Predict 73 Relapsed Refractory 73 Lung Cancer Patients 73 Advanced Ovarian Cancer 73 Carcinomas 73 Meets Primary Endpoint 73 Preclinical Models 73 Patients Receiving 73 Hepatitis C Virus 73 Squamous 73 HER2 Positive 73 Gene Linked 73 Ovarian Cancer Patients 73 Previously Treated 73 Cell Lymphoma 73 Patients Treated With 73 Colorectal Adenomas 73 Combination Treatment 73 Oral Fingolimod 73 Vaccine Candidate 73 Follicular Lymphoma 73 Treating Chronic 73 Anthracycline 73 Treatment Shows Promise 73 Predict Risk 72 Allergic Rhinitis 72 Endometrial 72 Brain Metastases 72 Drug Resistant 72 Rheumatoid Arthritis Patients 72 Inflammatory Markers 72 Complicated Skin 72 Chronic Hepatitis C 72 Colorectal Cancer Patients 72 Severe Asthma 72 Unresectable 72 Proves Effective 72 Antitumor Activity 72 Diffuse Large B 72 Patients Treated 72 Squamous Cell 72 Fungal Infections 72 Randomized Study 72 Myeloma Patients 72 Prostatic 72 Thromboembolism 72 Skin Cancers 72 Immune Responses 72 Epratuzumab 72 Autoimmune Diseases 72 Breast Cancer Cells 72 Clinical Outcome 72 Chronic Pelvic Pain 72 Investigational Agent 72 Epidermal Growth Factor Receptor 72 Relapsing Remitting Multiple Sclerosis 72 Basal Cell Carcinoma 72 Immune Mediated 72 Breast Cancer Treatment 72 Sustained Efficacy 72 Treatment Reduces 72 Non Alcoholic Fatty 72 Anti Tumor Activity 71 Shows Promise Against 71 Adenoma 71 Clinical Trial Results 71 Neoadjuvant Chemotherapy 71 Lung Cancers 71 Iron Overload 71 Demonstrates Efficacy 71 Chronic Myelogenous Leukemia 71 Knee Osteoarthritis 71 Bladder Cancer 71 Liver Failure 71 Neoadjuvant 71 Postmenopausal Women 71 Drug Combo 71 Overactive Bladder 71 Multiple Myeloma Patients 71 Virus Infection 71 Nymox NX 71 Chronic Hepatitis B 71 Chronic HCV 71 Tyrosine Kinase Inhibitor 71 Trial Evaluating 71 Localized Prostate Cancer 71 Bacterial Infections 71 Drug Prevents 71 Breast Tumors 71 Phase 2b Study 71 Tyrosine Kinase Inhibitors 71 Drug Shows Promise 71 Ischemic Stroke 71 Neoplasms 71 Artery Disease 71 Liver Tumors 71 Shows Promising 71 Small Intestine 71 Gene Mutations 71 Anti Tumor 71 Neovascular Age Related Macular 71 Infected Patients 71 Newly Diagnosed Multiple Myeloma 71 Tumor Growth 71 Adenomas 71 Benign Prostatic Hyperplasia 71 Novel Oral 71 Drug Candidate 71 Malignancies 71 Inflammatory Disease 71 Preclinical Study 71 Fracture Risk 71 Lowers Risk 71 Cognitive Impairment 71 Atopic Dermatitis 71 Emerging Therapies 71 Basal Cell 71 Genes Linked 71 Treatment Naive Patients 71 Appears Safe 71 Hepatocellular 71 Thyroid Cancer 71 Lung Cancer Survival 71 Cancer Cells 71 Study Evaluating 71 Brentuximab Vedotin SGN 71 Sipuleucel T 71 Colorectal Cancers 71 Enlarged Prostate 71 Lung Cancer Trial 71 Cardiovascular Outcomes 71 Myelodysplastic Syndrome MDS 70 CYT# potent vascular disrupting 70 Aggressive Prostate Cancer 70 Pulmonary Arterial Hypertension 70 Combination Therapy 70 Prophylactic Treatment 70 Allogeneic 70 Newly Diagnosed 70 Lymphocytic 70 Successfully Treated 70 Previously Untreated 70 Phase IIb Trial 70 Hormone Receptor Positive 70 Diabetic Nephropathy 70 Venous Thromboembolism 70 Unfractionated Heparin 70 Idiopathic Pulmonary Fibrosis 70 Esophageal Cancer 70 Serious Infections 70 Dendritic Cells 70 Node Positive 70 Myelofibrosis 70 Topical Treatment 70 Relapsing Multiple Sclerosis 70 Prostate Cancers 70 Genital Herpes 70 Elderly Patients 70 Phase III Clinical Trial 70 Bone Fractures 70 Metastatic 70 Combo Therapy 70 Subgroup Analysis 70 Renal Cancer 70 Insulin Resistance 70 basal cell carcinoma BCC 70 Treated Patients 70 Is Well Tolerated 70 metastatic malignant 70 Patients Undergoing 70 Progenitor Cells 70 Angioedema 70 Chronic Heart Failure 70 metastatic colorectal 70 Recurrent Breast Cancer 70 Myocardial Ischemia 70 Pancreatic Cancer 70 Preterm Delivery 70 Acute Myelogenous Leukemia 70 Septic Shock 70 Brain Tumors 70 Lung Cancer Drug 70 Thromboembolic 70 Heart Failure Patients 70 II Clinical Trial 70 Ovarian Cancers 70 Prostate Cancer Treatment 70 Respiratory Syncytial Virus 70 Diabetic Neuropathy 70 Placebo Controlled Study 70 Androgen Deprivation Therapy 70 Stem Cell Treatment 70 Refractory Hodgkin Lymphoma 70 Breast Cancer Patients 70 Hematological 70 Precancerous 70 Relapsed Multiple Myeloma 70 Investigational Treatment 70 Inhaled Corticosteroids 70 Pivotal Phase III 70 Hepatitis B Virus 70 Gene Variant 70 Peripheral Blood 70 Ischemic 70 Malaria Vaccine 70 Malignant Glioma 70 Advanced Colorectal Cancer 70 Kinase Inhibitor 70 Potentially Fatal 70 Myelodysplastic Syndrome 70 Kinase Inhibitors 69 Carcinoid 69 Cell Transplants 69 Randomized Phase II 69 Protein Linked 69 Cholangiocarcinoma 69 Thrombotic 69 Adenocarcinoma 69 Juvenile Idiopathic Arthritis 69 Therapeutic Effects 69 Interferon Beta 69 Epstein Barr Virus 69 Chronic Rhinosinusitis 69 Genes Associated 69 Chemoradiation 69 Multicenter Trial 69 Controlled Study 69 Monoclonal Antibody 69 Atypical Hemolytic Uremic Syndrome 69 Shows Efficacy 69 Nonalcoholic Fatty Liver Disease 69 Kidney Transplant Patients 69 Prognostic Significance 69 Well Tolerated 69 Minimally Invasive Treatment 69 Inflammatory Diseases 69 Hepatocellular Carcinoma HCC 69 Metastatic Renal Cell Carcinoma 69 Genetic Variation 69 Demonstrates Potent 69 Bacterial Infection 69 Cardiovascular Events 69 Cardiotoxicity 69 Graft Versus Host 69 Lymphoid 69 Dual Antiplatelet Therapy 69 Proven Effective 69 Obesity Linked 69 Antiangiogenic 69 Slows Progression 69 Liver Injury 69 Viral Infections 69 Efficacy Trial 69 Acute Renal Failure 69 colorectal carcinoma 69 TNF Blockers 69 Pediatric Patients 69 Cholesterol Lowering Drug 69 Potent Anti 69 Chronic Inflammation 69 Respiratory Distress 69 Critically Ill Patients 69 Blood Cancers 69 Acute Leukemia 69 Radical Prostatectomy 69 Prostate Cancer Vaccine 69 Bloodstream Infections 69 Preclinical Data 69 Genes Identified 69 Autoimmune Disorders 69 Breast Cancer Metastasis 69 Oral Cavity 69 Solid Tumors 69 Novel Treatments 69 Dose Finding 69 Genetic Variant 69 Effective Treatments 69 Premature Aging 69 Effectively Treats 69 Genetic Disorder 69 Novel Mechanism 69 Liver Metastases 69 Gastrointestinal Stromal Tumors 69 Prospective Randomized 69 Autologous Stem Cell Transplantation 69 Castration Resistant Prostate Cancer 69 Statistically Significant 69 Diabetic Patients 69 Resistant Hypertension 69 Anticancer Activity 69 Rheumatoid Arthritis RA 69 Brain Atrophy 69 Hepatitis C Infection 69 Carotid Stenting 69 Eculizumab 69 Circulating Tumor Cells 69 Pegylated Interferon 69 Initiates Clinical Trial 69 Cellular Immunotherapy 69 Phase 2b Trial 69 Anaplastic 69 Decitabine 69 Predict Breast Cancer 69 Vaccine Shows Promise 69 Oral Mucositis 69 Phase III Trials 69 Naive Patients 69 Subtypes 69 Rotavirus Vaccine 69 Monotherapy 69 Advanced Pancreatic Cancer 69 Radiofrequency Ablation 69 Skeletal Muscle 69 Fluorouracil 69 Iron Deficiency 69 Sapacitabine 69 Peripheral Artery Disease 69 Intracerebral Hemorrhage 69 Aurora Kinase 69 Lymph Node 69 Acute Ischemic Stroke 69 Dose Escalation 68 Statin Therapy 68 Premenopausal Women 68 Chemotherapy Induced 68 Gum Disease 68 Systemic Sclerosis 68 Immune Cells 68 Anticancer Drugs 68 Reovirus 68 Papillary 68 Bronchiectasis 68 Survival Rates 68 Urinary Tract Infections 68 Therapeutic Vaccine 68 Patients Suffering 68 Factor Receptor 68 Immunosuppression 68 Single Dose 68 Test Detects 68 Placebo Controlled Trial 68 Predict Response 68 Anticancer Drug 68 Stem Cell Transplant 68 Kidney Transplant Recipients 68 Pivotal Trial 68 Progressive Multifocal Leukoencephalopathy 68 Cancer Treatments 68 Invasive Fungal Infections 68 Vaginal Gel 68 Nilotinib 68 Randomized Phase 68 Reduces Mortality 68 Safinamide 68 Childhood Leukemia 68 Non Alcoholic Steatohepatitis 68 Prostate Tumors 68 Neural Stem Cells 68 Malignancy 68 AA Amyloidosis 68 Apaziquone 68 Novel Therapeutic 68 Investigational Drug 68 Postmenopausal Osteoporosis 68 Polymerase Inhibitor 68 Premature Infants 68 Completes Patient Enrollment 68 Renal Artery 68 Antigen Specific 68 Pivotal Clinical Trial 68 Mouse Models 68 Chronic Prostatitis 68 Irritable Bowel 68 Contrast Agents 68 Nephropathy 68 Lupus Drug 68 Chronic Lymphocytic Leukemia CLL 68 Cocaine Addiction 68 Vitro Activity 68 Pleural Mesothelioma 68 Hypertensive Patients 68 Androgen Independent 68 Signaling Pathway 68 Cardiovascular Disease Risk 68 Pivotal Phase 68 Uterine Fibroid Embolization 68 Receives Orphan Drug Designation 68 Cancer Patients Treated 68 Experimental Vaccine 68 complement inhibitor eculizumab 68 Fewer Side Effects 68 Rectal Cancer 68 Phase III Trial 68 Stem Cell Transplants 68 ST Elevation Myocardial 68 Philadelphia Chromosome Positive 68 Patient Enrollment 68 Paclitaxel Carboplatin 68 Nicotine Vaccine 68 Antibiotic Treatment 68 Genetic Mutation 68 invasive candidiasis 68 Increased Mortality 68 Vaccine Protects Against 68 JAK Inhibitor 68 Liver Cancer 68 Phase 2a Clinical Trial 68 Benign Prostatic Hyperplasia BPH 68 Protein Involved 68 Contralateral 68 Meningiomas 68 Uterine Cancer 68 Autoantibodies 68 Bone Metastases 68 Pralatrexate 68 Initiate Phase 68 Respiratory Virus 68 Endothelial Cells 68 Immunotherapeutic 68 Blood Clots 68 atypical Hemolytic Uremic Syndrome 68 Male Infertility 68 Cancer Recurrence 68 Long Term Efficacy 68 Breast Density 68 Genetic Variations 68 Bevacizumab 68 MRSA Infections 68 Hyperplasia 68 Prostate Cancer Progression 68 Catheter Associated 68 Stent Thrombosis 68 Therapeutic Potential 68 Pharmacokinetic Study 68 Muscle Function 68 Diabetic Neuropathic Pain 68 Alveolar 68 Viral Load 68 Colon Polyps 68 Acute Myeloid Leukemia 68 Systemic Delivery 68 Hsp# Inhibitor 68 Trastuzumab 68 Sleep Disturbances 68 Hepatotoxicity 68 Osteoporosis Drugs 68 Phase 1b Clinical Trial 68 Meta Analysis 68 Chronic Inflammatory 68 Novel Antibiotic 68 Taxane 68 Angiogenic 68 Non Melanoma Skin 68 Intracerebral 68 Immune Cell 68 leukemia AML 68 Estrogen Receptor 68 Benign prostatic hyperplasia BPH 68 Cytomegalovirus 68 Prognostic Value 68 Osteoporotic 68 Valopicitabine 67 Skin Structure Infections 67 Cardiovascular Mortality 67 Ischaemic 67 Diabetic Ulcers 67 Asymptomatic 67 Antiviral Therapy 67 Inactivation 67 Etiology 67 Adenoviral 67 Anti Angiogenesis 67 Tumor Suppressor 67 Parathyroid 67 Neoplasia 67 Bosutinib 67 Hormone Therapy 67 Controlled Trial 67 Phase III Clinical Trials 67 Paraplatin ® 67 Investigational Compound 67 receptor tyrosine kinase inhibitor 67 Advaxis Phase 67 Often Misdiagnosed 67 Pulmonary Hypertension 67 Pivotal Study 67 Pharmacokinetics PK 67 RNAi Therapeutic 67 Dasatinib 67 cutaneous melanoma 67 Adjunctive Therapy 67 Multicenter Randomized 67 PKC# 67 Tumor Suppressor Gene 67 Smooth Muscle 67 pan HDAC inhibitor 67 Peginterferon 67 Osteoporosis Treatment 67 ErbB2 positive 67 resistant hormone refractory 67 Hematologic 67 Breast Cancer Stem Cells 67 Antitumor 67 Beta Blockers 67 Epstein Barr Virus EBV 67 IND Application 67 See CLINICAL PHARMACOLOGY 67 Tumor Targeting 67 Leukemia Cells 67 Drug Resistant Bacteria 67 Antiviral Activity 67 Prostate Cancer Screening 67 Radioimmunotherapy 67 Psychiatric Disorders 67 Pancreatic 67 Cervical Disease 67 Treatable 67 HCV Protease Inhibitor 67 Tumor Necrosis Factor 67 Uterine Fibroids 67 Hemorrhagic Stroke 67 recurrent glioblastoma multiforme 67 Epileptic Seizures 67 hepatocellular cancer 67 Fludarabine 67 Mantle Cell Lymphoma 67 Disease Modifying 67 Hyperlipidemia 67 Targeted Therapies 67 TB Vaccine 67 Fallopian Tube 67 Cancer Immunotherapy 67 Antiviral Drugs 67 Left Ventricular 67 Chronic Renal Failure 67 Cognitive Decline 67 External Beam 67 Fast Track Status 67 Gene Variation 67 Study Showed 67 leiomyomas 67 Novel Inhibitor 67 Acute Coronary Syndromes 67 Hemodialysis Patients 67 Virus Linked 67 Plus Ribavirin 67 Lung Tumors 67 Cognitive Deficits 67 Oral Cladribine 67 Phase 2a Trial 67 familial amyloidotic polyneuropathy FAP 67 ATTR CM 67 Kidney Failure 67 Epilepsy Drugs 67 relapsed MM 67 Therapy Shows Promise 67 FDA Approves Drug 67 metastatic gastric 67 Tigecycline 67 Chronic lymphocytic leukemia 67 Rheumatoid 67 Infarct 67 Granted Orphan Drug 67 Genetic Tests 67 Hemorrhagic 67 Newly Diagnosed Patients 67 Chemotherapy Improves 67 Tumor Cells 67 metastatic neuroendocrine tumors 67 Receptor Agonist 67 simplex virus 67 Certain Cancers 67 Therapeutic Vaccines 67 Bazedoxifene 67 Protease Inhibitors 67 Viral Infection 67 Cervical Dysplasia 67 Reduced Risk 67 Therapeutic Antibody 67 Glioblastoma 67 Male Contraceptive 67 Cyclophosphamide 67 Xenografts 67 Arterial Disease 67 ADPKD 67 Pemphigus Vulgaris 67 Aflibercept 67 leukemia ALL 67 choriocarcinoma 67 Epilepsy Drug 67 Eye Diseases 67 Hepatitis B Vaccine 67 Toxicities 67 Breast Tissue 67 Beneficial Effects 67 Completes Enrollment 67 Urinary Incontinence 67 Skin Lesions 67 Vasculitis 67 Migraine Headaches 67 Genes Involved 67 Vaccine Adjuvant 67 Secondary Hyperparathyroidism 67 PEGylated Fab fragment 67 Boosts Survival 67 Diabetic Retinopathy 67 Treatment Naive 67 Unstable Angina 67 Successfully Completes Phase 67 Patient Outcomes 67 Novel Vaccine 67 Replacement Therapy 67 Gliomas 67 Genetic Predisposition 67 gastric adenocarcinoma 67 Microalbuminuria 67 Critical Limb Ischemia 67 epithelial ovarian 67 biliary tract cancer 67 FISH Probe 67 Coronary Artery 66 Clostridium difficile Infection 66 dasatinib Sprycel ® 66 Renal Impairment 66 Metabolic Disorders 66 Ofatumumab 66 Cholesterol Levels SPARCL 66 Epithelial Cell 66 Diabetic Macular Edema 66 Phase IIb Clinical Trial 66 Temsirolimus 66 Hedgehog Pathway 66 Transdermal Patch 66 Cytotoxicity 66 Ozarelix 66 Antibiotic Resistant 66 Renal Cell Cancer 66 Venous Thrombosis 66 Leber Hereditary Optic Neuropathy 66 Files IND 66 Chemoprevention 66 Acute Heart Failure 66 Critical Limb Ischemia CLI 66 unresectable stage 66 Hepatic Encephalopathy 66 squamous cell carcinoma SCC 66 Inflammatory Arthritis 66 Allergic Asthma 66 Irinotecan 66 Gout Drug 66 Diabetic Foot Ulcers 66 Bone Marrow Transplants 66 Drug Combinations 66 Helicobacter Pylori 66 Enzyme Replacement Therapy 66 Prognostic Factors 66 Hormone Receptor 66 fallopian tube carcinoma 66 Treatment Naïve Patients 66 Anti Inflammatory Drug 66 Blood Transfusions 66 Brain Aneurysms 66 ACE Inhibitors 66 IIa Clinical Trial 66 nonmetastatic 66 Monoclonal Antibodies 66 Ranolazine 66 Cerebril TM 66 Genital Warts 66 Respiratory Infections 66 Stage IIB 66 Bacterial Vaginosis 66 Cerebrospinal Fluid 66 GW# [003] 66 Coronary Arteries 66 Nitazoxanide 66 LHRH receptor positive 66 Statin Drugs 66 chronic myeloid 66 Dengue Virus 66 Hematopoietic 66 Myocarditis 66 lymphoid malignancies 66 First Patient Dosed 66 Neck Cancers 66 Early Diagnosis 66 Prevent Breast Cancer 66 chronic eosinophilic leukemia 66 Double Blind Placebo 66 gastrointestinal stromal tumors GIST 66 Acute Myocardial Infarction 66 Lenalidomide 66 Degarelix 66 Neovascularization 66 Renal Anemia 66 Erectile Dysfunction Drug 66 HCV Infection 66 Omacetaxine 66 Organ Rejection 66 Commonly Used 66 FDA Approvals 66 Lymphoma Patients 66 Pre Cancerous 66 Transplant Patients 66 Genetic Marker 66 Treating Heart Failure 66 Golimumab 66 Demonstrates Positive 66 Neuroprotective Effects 66 Severe Acne 66 Recurrences 66 Initiates Phase III 66 Etanercept 66 Radiation Induced 66 Menopausal Women 66 Drug Resistant TB 66 Drug Eluting 66 gastrointestinal stromal tumors GISTs 66 Cancer Therapies 66 Elevated Levels 66 Bone Marrow Cells 66 Parathyroid Hormone 66 Less Invasive 66 Rare Genetic 66 Randomized Double blind 66 Systemic Lupus Erythematosus SLE 66 Diabetic Foot Ulcer 66 recurrent glioma 66 Dupuytren Contracture 66 Intravenous Formulation 66 Cancer Vaccines 66 Randomized Controlled 66 Ultrasensitive 66 Increases Risk 66 Cytotoxic T 66 Oxidative Stress 66 Hematological Malignancies 66 Cell Proliferation 66 HPV Infection 66 Hepatitis C Patients 66 Peptic Ulcer 66 Mimetics 66 Stent Restenosis 66 Predict Prostate Cancer 66 Meningococcal Disease 66 Refractory Angina 66 Cystectomy 66 Left Ventricular Hypertrophy 66 Prostate Cancer Survival 66 Vicriviroc 66 Beta Blocker 66 Acute Pancreatitis 66 Multiple Myeloma MM 66 Anthrax Toxin 66 Systemic Lupus Erythematosus 66 Present Preclinical Data 66 Mucositis 66 Hypercholesterolemia 66 Papillomavirus 66 cell lymphoma CTCL 66 Alemtuzumab 66 Pancreas Cancer 66 Kidney Transplants 66 FDA Okays 66 Enzastaurin 66 Cancer Stem Cells 66 FOLOTYN ® 66 Mucosal 66 cytomegalovirus infection 66 Epstein Barr virus EBV 66 Herpes Simplex 66 Collaborators Present 66 recurrent glioblastoma multiforme GBM 66 HER2 overexpression 66 Amniotic Fluid 66 Breast Tumor 66 Cholesterol Levels 66 Fibroblast 66 Anal Cancer 66 Allergic Reactions 66 antibody MAb 66 Thyroid Hormone 66 Metabolic Disorder 66 Therapeutic Antibodies 66 Carcinoid Syndrome 66 Metastatic Breast Cancer 66 Renal Function 66 Chronic Myelogenous Leukemia CML 66 Ankylosing Spondylitis 66 Genetic Mutations 66 Helps Predict 66 Ibritumomab Tiuxetan 66 Gene Therapy Trial 66 C1 Inhibitor 66 Cutaneous Melanoma 66 Immunomodulatory 66 Hyperkalemia 66 Kidney Function 66 stage IIIB 66 Demonstrates Significant 66 Universal Flu Vaccine 66 Achieves Primary Endpoint 66 Targeted Therapy 66 Therapeutic Efficacy 66 Non Invasive Treatment 66 Oncolytic 66 Pemetrexed 66 Acute Exacerbations 66 Treatment Regimen 66 Neuroprotection 66 Stress Urinary Incontinence 66 Antiplatelet 66 MKC# MT 66 Kidney Stones 66 Muscle Wasting 66 Blood Vessels 66 Oncologic 66 Epithelial 66 STRIDE PD 66 Ductal Carcinoma 66 Stable Coronary Artery 66 Reflux Disease 66 Blood Pressure Drug 66 Paroxysmal Nocturnal Hemoglobinuria PNH 66 Inhibits 66 Postmenopausal 66 Dose Ranging Study 66 Non Responders 66 Growth Hormone Deficiency 66 Endothelial Function 66 Chronic Kidney 66 seminoma 65 Combination Clinical Trial 65 Protease Inhibitor 65 Nerve Cells 65 Multicenter Study 65 Phase IIa Clinical Trial 65 Anticoagulant 65 Gaucher Disease 65 HCV Genotype 65 Genetic Basis 65 Transcription Factor 65 Randomized Trials 65 Aggressive Reduction 65 Albuferon TM 65 Myeloid 65 Cytomegalovirus CMV 65 First Patient Treated 65 keloid scarring 65 Chemotherapeutic Agents 65 Therapy Improves 65 Peginterferon Alfa 2a 65 Sezary syndrome 65 Human Neural Stem 65 Rheumatoid Arthritis Drug 65 Initiates Clinical 65 Cardiac Function 65 Diagnostic Criteria 65 Confirms Efficacy 65 Relapsed Refractory Aggressive 65 Metabolic Disease 65 Efficacious 65 Stent Implantation 65 Estrogen Therapy 65 Anti VEGF 65 Minimally Invasive Procedure 65 Osteoporosis Drug 65 Occlusive Disease 65 Telaprevir VX 65 Peripheral Arterial 65 Long Term Survival 65 Polycystic Ovary Syndrome 65 Skin Structure Infections ABSSSI 65 ST Segment Elevation 65 Colorectal 65 Squamous cell 65 Randomized Clinical Trial 65 castrate resistant prostate cancer 65 Premature Births 65 Chronic Lyme Disease 65 situ CIS 65 Retreatment 65 Glufosfamide 65 Newly Diagnosed Breast Cancer 65 abacavir Ziagen 65 Pneumococcal Vaccine 65 Aliskiren 65 Respiratory Syncytial Virus RSV 65 Metastatic Cancer 65 Smallpox Vaccine 65 Keratosis 65 Portal Hypertension 65 Oral Calcitonin 65 Phase III Pivotal 65 Antifungal 65 Hospital Acquired Pneumonia 65 Keratitis 65 Cyclooxygenase 2 65 Smoking Linked 65 mycosis fungoides 65 Clinical Trial Data 65 prostate cancer mCRPC 65 Gene Variants 65 Heart Ailments 65 Overactive Bladder OAB 65 Node Negative 65 Acute myeloid leukemia 65 Thiazolidinediones 65 erythematosus 65 Recombinant Human 65 Obese Patients 65 Protein Kinase 65 hepatocellular carcinoma HCC 65 Acute Bacterial Skin 65 Treatment Resistant 65 BRAF V#E 65 Increased Risk 65 Chemotherapy Regimen 65 Cell Transplant 65 Complete Remission 65 Pulmonary Artery 65 Radiofrequency Ablation RFA 65 myelofibrosis polycythemia vera 65 Chronic Lung 65 Acute Myeloid Leukemia AML 65 Syncria R 65 Human Monoclonal Antibody 65 Cognitive Problems 65 Pelvic Organ Prolapse 65 ZACTIMA TM ZD# 65 Preterm Infants 65 Rheumatoid Arthritis 65 Natalizumab 65 Metastatic Pancreatic Cancer 65 Physician Insights 65 Survival Rate 65 Cystic 65 Liver Cirrhosis 65 Gram Positive 65 testicular cancers 65 Chronic Bronchitis 65 Diagnostic Tests 65 Antiplatelet Therapy 65 Brain Scans 65 Azacitidine 65 Lymphomas 65 Breast Cancer Risk 65 Tezampanel 65 Vitamin D Deficiency 65 Breast Carcinoma